Travere Therapeutics CEO Eric M. Dube reports sale of $13.12 million in common shares
TVTX•Travere Therapeutics CEO Eric M. Dube sold 243,735 common shares on October 15, 2026. He exercised options for 243,735 shares at prices of $26.88 and $8.93, and held 432,886 shares directly after the transactions.
1. Share transactions
Dube sold 243,735 common shares on October 15, 2026: 128,065 at $52.9672, 37,270 at $54.1997 and 78,400 at $55.0179. He exercised employee stock options for 43,735 shares at $26.88 per share and separately exercised options for 200,000 shares at $8.93 per share. His direct common stock holdings stood at 432,886 shares following the transactions.
